KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Cash from Investing Activities (2016 - 2026)

Pfizer has reported Cash from Investing Activities over the past 18 years, most recently at $785.0 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 76.02% to $785.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$3.8 billion through Mar 2026, down 127.66% year-over-year, with the annual reading at -$1.4 billion for FY2025, 150.94% down from the prior year.
  • Cash from Investing Activities was $785.0 million for Q1 2026 at Pfizer, up from -$6.1 billion in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $4.6 billion in Q2 2024 and troughed at -$25.5 billion in Q3 2023.
  • The 5-year median for Cash from Investing Activities is $785.0 million (2026), against an average of -$3.0 billion.
  • Year-over-year, Cash from Investing Activities surged 484.66% in 2023 and then crashed 156.84% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$11.4 billion in 2022, then increased by 3.31% to -$11.0 billion in 2023, then surged by 138.88% to $4.3 billion in 2024, then plummeted by 243.77% to -$6.1 billion in 2025, then soared by 112.77% to $785.0 million in 2026.
  • Per Business Quant, the three most recent readings for PFE's Cash from Investing Activities are $785.0 million (Q1 2026), -$6.1 billion (Q4 2025), and -$2.4 billion (Q3 2025).